Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders

被引：12

作者：

Tang, Baiyu ^{[1
]}

Su, Feng ^{[1
]}

Sun, Xiangke ^{[1
]}

Wu, Qin ^{[2
]}

Xing, Quansheng ^{[2
]}

Li, Suming ^{[3
]}

机构：

[1] Qingdao Univ Sci & Technol, Coll Chem Engn, Qingdao 266042, Peoples R China

[2] Qingdao Univ, Qingdao Childrens Heart Ctr, Congenital Heart Dieases Res Ctr, Qingdao Women & Childrens Hosp, Qingdao 266034, Peoples R China

[3] Univ Montpellier, Inst Europeen Membranes, CNRS, UMR 5635, F-34095 Montpellier, France

来源：

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS | 2018年 / 106卷 / 01期

基金：

美国国家科学基金会;

关键词：

atrial septal defect; patent foramen ovale; occluder; biodegradable; 1,000 CONSECUTIVE PATIENTS; CONGENITAL HEART-DISEASE; SINGLE-CENTER EXPERIENCE; PERCUTANEOUS CLOSURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; THROMBUS FORMATION; DEVICE; MULTICENTER; PFO; OCCLUTECH(A(R));

D O I：

10.1002/jbm.b.33831

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

Atrial septal defect (ASD) and patent foramen ovale (PFO) are common clinical congenital heart defects. As an effective method for the treatment of ASD and PFO, transcatheter closure with occluders presents many advantages, including safety, ease of operation, minimal invasiveness, and reduced complications. This contribution reviews the various types of occluders currently used in clinical applications and under development, including non degradable occluders, partially degradable occluders, and totally degradable occluders. A number of case studies are described in detail. Comparison is made on the treatment outcomes using different occulders. Future development of transcatheter closure is discussed, in particular the use of totally degradable occluders. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 433-443, 2018.

引用

页码：433 / 443

页数：11

共 44 条

[1] Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices [J].

Anzai, H ;

Child, J ;

Natterson, B ;

Krivokapich, J ;

Fishbein, MC ;

Chan, VK ;

Tobis, JM .

AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (04) :426-431

[2]

Babic U U, 1991, J Interv Cardiol, V4, P283, DOI 10.1111/j.1540-8183.1991.tb00810.x

[3] Racial and temporal variations in the prevalence of heart defects [J].

Botto, LD ;

Correa, A ;

Erickson, JD .

PEDIATRICS, 2001, 107 (03) :E32

[4] TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE AFTER PRESUMED PARADOXICAL EMBOLISM [J].

BRIDGES, ND ;

HELLENBRAND, W ;

LATSON, L ;

FILIANO, J ;

NEWBURGER, JW ;

LOCK, JE .

CIRCULATION, 1992, 86 (06) :1902-1908

[5]

Buscheck Franziska, 2006, J Interv Cardiol, V19, P328, DOI 10.1111/j.1540-8183.2006.00154.x

[6]

Carminati M, 2000, CARDIOL YOUNG, V10, P519

[7] Incidence of patent ductus arteriosus and patent foramen ovale in normal infants [J].

Connuck, D ;

Sun, JP ;

Super, DM ;

Kirchner, HL ;

Fradley, LG ;

Harcar-Sevcik, RA ;

Salvator, A ;

Singer, L ;

Mehta, SK .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (02) :244-+

[8] Mid-term Outcomes of the Helex Septal Occluder for Percutaneous Closure of Secundum Atrial Septal Defects [J].

Correa, Rafael ;

Zahn, Evan ;

Khan, Danyal .

CONGENITAL HEART DISEASE, 2013, 8 (05) :428-433

[9] EXPERIMENTAL ATRIAL SEPTAL-DEFECT CLOSURE WITH A NEW, TRANSCATHETER, SELF-CENTERING DEVICE [J].

DAS, GS ;

VOSS, G ;

JARVIS, G ;

WYCHE, K ;

GUNTHER, R ;

WILSON, RF .

CIRCULATION, 1993, 88 (04) :1754-1764

[10]

Das GS, 1996, CIRCULATION, V94, P320

← 1 2 3 4 5 →